A 40-year-old man said in a complaint seen by Reuters that he had suffered serious "neurological and psychological" symptoms after receiving the vaccine in a trial being run by the British drugmaker's partner Serum Institute of India (SII). As India readies vaccine strategy, Modi warns of possible side-effectsLaw firm N.G.R. "While the Serum Institute of India is sympathetic with the volunteer's medical condition, there's absolutely no correlation with the vaccine trial," SII said. "(The) volunteer was specifically informed by the medical team that the complications he suffered were independent of the vaccine trial he underwent," it added. The Drugs Controller General of India, who is responsible for drug and vaccine approval, could not immediately be reached for comment on Sunday.

Source: bd News24 November 29, 2020 17:03 UTC